+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Burn Ointment Market By Depth of Burn, By Product, By End Use, By Region, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241445
  • Report
  • January 2021
  • Region: Global
  • 198 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Cipla Limited
  • ConvaTec Group PLC
  • Dr. Morepen Limited
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Mankind Pharma Ltd.
  • MORE
The Global Burn Ointment Market size is expected to reach $1.1 billion by 2026, rising at a market growth of 5.7% CAGR during the forecast period. Burn is a form of physical injury that is caused by heat exposure from electrical, chemical, electromagnetic, or thermal energy. Depending upon the size & depth of the burn, the severity of the burn is decided.

On the basis of severity, burns are classified as first-degree, second-degree, and third-degree burns. Burn injuries are managed accordingly on the basis of the degree of injury. Advanced burn care, biologics, and traditional burn care are some of the products that are used in the treatment of burn care. These products are helpful in preventing complications like reducing scarring risk, control pain, prevent infection, remove dead tissue, and regain function.

The severity of burn injury depends on the intensity and size of the burn. Burns from hot liquids, hot bathing water, boiling water, steam, hot drinks, and cooking oil causes scalding. Children suffer from accidental burns. Treatment of these burn conditions is done based of the degree of damage. The demand for the various burn treatment option has been increased due to an increasing incidence of burn wounds.

To prevent the risk of hospital-acquired infection (HAI) in patients, companies involved in manufacturing healthcare products including burn injury treatment are bringing improved silver sulfadiazine (SSD) creams that minimize complications and other health risks. Healthcare professionals are looking towards the expertise of scientists and researchers to do experiments on silver-containing dressings with honey, since honey offers antiseptic effects that causes faster healing of burn injuries. Healthcare companies are focused to increase their research on dressings infused with sodium hypochlorite that may give faster healing results if compared to SSD dressings.



By Product

Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. The topical antibiotics segment holds the largest market share in 2019. The segment growth is mainly driven by the high usage of topical antibiotics in home-care settings and the increasing incidence of blaze wounds across the world. Mafenide acetate, Mupirocin, Neosporin, Bacitracin, Polymyxin B, Nitrofurazone, and Nystatin are some of the topical antibiotics that are available in the market.



By Depth of Burn

Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. The partial thickness burn segment is expected to show the fast growth over the forecast period. Any burn that damages more than 10.0% and less than 30.0% of Total Body Surface Area (TBSA) is called partial thickness burn. In partial burns, the dermis and epidermis layers of the skin is affected and have a higher risk of infections that is why these types of burns should be properly treated by consulting a healthcare professional.

By End Use

Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. The hospital segment led the burn ointment market and had the largest revenue share in 2019. This is due to the increasing cases of blaze wounds and hospitalizations of patients each year. According to NCBI, about 486,000 people are suffered from blaze wounds every year. According to CDC, around 40,000 patients who severely burned get hospitalized each year in the U.S. Furthermore, according to a study published by NCBI, in Africa, about 18.0% of the hospitalizations are due to burns. The increasing rate of blaze wounds is likely to boost the demand for ointments.

By Region

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America led the market and had the largest revenue share in 2019. The growth is accredited to the increasing occurrence of burns and rising awareness about various treatment options of burn wounds are likely to boost demand for blaze wound ointments in this region. Furthermore, the presence of strategic market players in this region who are focusing on planned initiatives like the launch of new products and mergers and acquisitions. These factors are anticipated to create lucrative growth opportunities for the market players in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.

Scope of the Study

Market Segments covered in the Report:

By Depth of Burn
  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns
By Product
  • Topical Antibiotics
  • Silver
  • Iodine
  • Other Products
By End Use
  • Clinics
  • Hospitals
  • Other End Use
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • Johnson and Johnson
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Perrigo Company PLC
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Morepen Limited
  • Mankind Pharma Ltd.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cipla Limited
  • ConvaTec Group PLC
  • Dr. Morepen Limited
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Mankind Pharma Ltd.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Burn Ointment Market, by Depth of Burn
1.4.2 Global Burn Ointment Market, by Product
1.4.3 Global Burn Ointment Market, by End Use
1.4.4 Global Burn Ointment Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Burn Ointment Market by Depth of Burn
3.1 Global Minor Burns Market by Region
3.2 Global Partial Thickness Burns Market by Region
3.3 Global Full Thickness Burns Market by Region

Chapter 4. Global Burn Ointment Market by Product
4.1 Global Topical Antibiotics Market by Region
4.2 Global Silver Market by Region
4.3 Global Iodine Market by Region
4.4 Global Other Products Market by Region

Chapter 5. Global Burn Ointment Market by End Use
5.1 Global Clinics Burn Ointment Market by Region
5.2 Global Hospitals Market by Region
5.3 Global Other End Use Market by Region

Chapter 6. Global Burn Ointment Market by Region
6.1 North America Burn Ointment Market
6.1.1 North America Burn Ointment Market by Depth of Burn
6.1.1.1 North America Minor Burns Market by Country
6.1.1.2 North America Partial Thickness Burns Market by Country
6.1.1.3 North America Full Thickness Burns Market by Country
6.1.2 North America Burn Ointment Market by Product
6.1.2.1 North America Topical Antibiotics Market by Country
6.1.2.2 North America Silver Market by Country
6.1.2.3 North America Iodine Market by Country
6.1.2.4 North America Other Products Market by Country
6.1.3 North America Burn Ointment Market by End Use
6.1.3.1 North America Clinics Burn Ointment Market by Country
6.1.3.2 North America Hospitals Market by Country
6.1.3.3 North America Other End Use Market by Country
6.1.4 North America Burn Ointment Market by Country
6.1.4.1 US Burn Ointment Market
6.1.4.1.1 US Burn Ointment Market by Depth of Burn
6.1.4.1.2 US Burn Ointment Market by Product
6.1.4.1.3 US Burn Ointment Market by End Use
6.1.4.2 Canada Burn Ointment Market
6.1.4.2.1 Canada Burn Ointment Market by Depth of Burn
6.1.4.2.2 Canada Burn Ointment Market by Product
6.1.4.2.3 Canada Burn Ointment Market by End Use
6.1.4.3 Mexico Burn Ointment Market
6.1.4.3.1 Mexico Burn Ointment Market by Depth of Burn
6.1.4.3.2 Mexico Burn Ointment Market by Product
6.1.4.3.3 Mexico Burn Ointment Market by End Use
6.1.4.4 Rest of North America Burn Ointment Market
6.1.4.4.1 Rest of North America Burn Ointment Market by Depth of Burn
6.1.4.4.2 Rest of North America Burn Ointment Market by Product
6.1.4.4.3 Rest of North America Burn Ointment Market by End Use
6.2 Europe Burn Ointment Market
6.2.1 Europe Burn Ointment Market by Depth of Burn
6.2.1.1 Europe Minor Burns Market by Country
6.2.1.2 Europe Partial Thickness Burns Market by Country
6.2.1.3 Europe Full Thickness Burns Market by Country
6.2.2 Europe Burn Ointment Market by Product
6.2.2.1 Europe Topical Antibiotics Market by Country
6.2.2.2 Europe Silver Market by Country
6.2.2.3 Europe Iodine Market by Country
6.2.2.4 Europe Other Products Market by Country
6.2.3 Europe Burn Ointment Market by End Use
6.2.3.1 Europe Clinics Burn Ointment Market by Country
6.2.3.2 Europe Hospitals Market by Country
6.2.3.3 Europe Other End Use Market by Country
6.2.4 Europe Burn Ointment Market by Country
6.2.4.1 Germany Burn Ointment Market
6.2.4.1.1 Germany Burn Ointment Market by Depth of Burn
6.2.4.1.2 Germany Burn Ointment Market by Product
6.2.4.1.3 Germany Burn Ointment Market by End Use
6.2.4.2 UK Burn Ointment Market
6.2.4.2.1 UK Burn Ointment Market by Depth of Burn
6.2.4.2.2 UK Burn Ointment Market by Product
6.2.4.2.3 UK Burn Ointment Market by End Use
6.2.4.3 France Burn Ointment Market
6.2.4.3.1 France Burn Ointment Market by Depth of Burn
6.2.4.3.2 France Burn Ointment Market by Product
6.2.4.3.3 France Burn Ointment Market by End Use
6.2.4.4 Russia Burn Ointment Market
6.2.4.4.1 Russia Burn Ointment Market by Depth of Burn
6.2.4.4.2 Russia Burn Ointment Market by Product
6.2.4.4.3 Russia Burn Ointment Market by End Use
6.2.4.5 Spain Burn Ointment Market
6.2.4.5.1 Spain Burn Ointment Market by Depth of Burn
6.2.4.5.2 Spain Burn Ointment Market by Product
6.2.4.5.3 Spain Burn Ointment Market by End Use
6.2.4.6 Italy Burn Ointment Market
6.2.4.6.1 Italy Burn Ointment Market by Depth of Burn
6.2.4.6.2 Italy Burn Ointment Market by Product
6.2.4.6.3 Italy Burn Ointment Market by End Use
6.2.4.7 Rest of Europe Burn Ointment Market
6.2.4.7.1 Rest of Europe Burn Ointment Market by Depth of Burn
6.2.4.7.2 Rest of Europe Burn Ointment Market by Product
6.2.4.7.3 Rest of Europe Burn Ointment Market by End Use
6.3 Asia Pacific Burn Ointment Market
6.3.1 Asia Pacific Burn Ointment Market by Depth of Burn
6.3.1.1 Asia Pacific Minor Burns Market by Country
6.3.1.2 Asia Pacific Partial Thickness Burns Market by Country
6.3.1.3 Asia Pacific Full Thickness Burns Market by Country
6.3.2 Asia Pacific Burn Ointment Market by Product
6.3.2.1 Asia Pacific Topical Antibiotics Market by Country
6.3.2.2 Asia Pacific Silver Market by Country
6.3.2.3 Asia Pacific Iodine Market by Country
6.3.2.4 Asia Pacific Other Products Market by Country
6.3.3 Asia Pacific Burn Ointment Market by End Use
6.3.3.1 Asia Pacific Clinics Burn Ointment Market by Country
6.3.3.2 Asia Pacific Hospitals Market by Country
6.3.3.3 Asia Pacific Other End Use Market by Country
6.3.4 Asia Pacific Burn Ointment Market by Country
6.3.4.1 China Burn Ointment Market
6.3.4.1.1 China Burn Ointment Market by Depth of Burn
6.3.4.1.2 China Burn Ointment Market by Product
6.3.4.1.3 China Burn Ointment Market by End Use
6.3.4.2 Japan Burn Ointment Market
6.3.4.2.1 Japan Burn Ointment Market by Depth of Burn
6.3.4.2.2 Japan Burn Ointment Market by Product
6.3.4.2.3 Japan Burn Ointment Market by End Use
6.3.4.3 India Burn Ointment Market
6.3.4.3.1 India Burn Ointment Market by Depth of Burn
6.3.4.3.2 India Burn Ointment Market by Product
6.3.4.3.3 India Burn Ointment Market by End Use
6.3.4.4 South Korea Burn Ointment Market
6.3.4.4.1 South Korea Burn Ointment Market by Depth of Burn
6.3.4.4.2 South Korea Burn Ointment Market by Product
6.3.4.4.3 South Korea Burn Ointment Market by End Use
6.3.4.5 Singapore Burn Ointment Market
6.3.4.5.1 Singapore Burn Ointment Market by Depth of Burn
6.3.4.5.2 Singapore Burn Ointment Market by Product
6.3.4.5.3 Singapore Burn Ointment Market by End Use
6.3.4.6 Malaysia Burn Ointment Market
6.3.4.6.1 Malaysia Burn Ointment Market by Depth of Burn
6.3.4.6.2 Malaysia Burn Ointment Market by Product
6.3.4.6.3 Malaysia Burn Ointment Market by End Use
6.3.4.7 Rest of Asia Pacific Burn Ointment Market
6.3.4.7.1 Rest of Asia Pacific Burn Ointment Market by Depth of Burn
6.3.4.7.2 Rest of Asia Pacific Burn Ointment Market by Product
6.3.4.7.3 Rest of Asia Pacific Burn Ointment Market by End Use
6.4 LAMEA Burn Ointment Market
6.4.1 LAMEA Burn Ointment Market by Depth of Burn
6.4.1.1 LAMEA Minor Burns Market by Country
6.4.1.2 LAMEA Partial Thickness Burns Market by Country
6.4.1.3 LAMEA Full Thickness Burns Market by Country
6.4.2 LAMEA Burn Ointment Market by Product
6.4.2.1 LAMEA Topical Antibiotics Market by Country
6.4.2.2 LAMEA Silver Market by Country
6.4.2.3 LAMEA Iodine Market by Country
6.4.2.4 LAMEA Other Products Market by Country
6.4.3 LAMEA Burn Ointment Market by End Use
6.4.3.1 LAMEA Clinics Burn Ointment Market by Country
6.4.3.2 LAMEA Hospitals Market by Country
6.4.3.3 LAMEA Other End Use Market by Country
6.4.4 LAMEA Burn Ointment Market by Country
6.4.4.1 Brazil Burn Ointment Market
6.4.4.1.1 Brazil Burn Ointment Market by Depth of Burn
6.4.4.1.2 Brazil Burn Ointment Market by Product
6.4.4.1.3 Brazil Burn Ointment Market by End Use
6.4.4.2 Argentina Burn Ointment Market
6.4.4.2.1 Argentina Burn Ointment Market by Depth of Burn
6.4.4.2.2 Argentina Burn Ointment Market by Product
6.4.4.2.3 Argentina Burn Ointment Market by End Use
6.4.4.3 UAE Burn Ointment Market
6.4.4.3.1 UAE Burn Ointment Market by Depth of Burn
6.4.4.3.2 UAE Burn Ointment Market by Product
6.4.4.3.3 UAE Burn Ointment Market by End Use
6.4.4.4 Saudi Arabia Burn Ointment Market
6.4.4.4.1 Saudi Arabia Burn Ointment Market by Depth of Burn
6.4.4.4.2 Saudi Arabia Burn Ointment Market by Product
6.4.4.4.3 Saudi Arabia Burn Ointment Market by End Use
6.4.4.5 South Africa Burn Ointment Market
6.4.4.5.1 South Africa Burn Ointment Market by Depth of Burn
6.4.4.5.2 South Africa Burn Ointment Market by Product
6.4.4.5.3 South Africa Burn Ointment Market by End Use
6.4.4.6 Nigeria Burn Ointment Market
6.4.4.6.1 Nigeria Burn Ointment Market by Depth of Burn
6.4.4.6.2 Nigeria Burn Ointment Market by Product
6.4.4.6.3 Nigeria Burn Ointment Market by End Use
6.4.4.7 Rest of LAMEA Burn Ointment Market
6.4.4.7.1 Rest of LAMEA Burn Ointment Market by Depth of Burn
6.4.4.7.2 Rest of LAMEA Burn Ointment Market by Product
6.4.4.7.3 Rest of LAMEA Burn Ointment Market by End Use

Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.2 ConvaTec Group PLC
7.2.1 Company Overview
7.2.1 Financial Analysis
7.2.2 Regional Analysis
7.2.3 Research & Development Expense
7.3 Smith & Nephew PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Approvals:
7.6 Perrigo Company PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Cipla Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Dr. Morepen Limited
7.9.1 Company Overview
7.10. Mankind Pharma Ltd.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
Note: Product cover images may vary from those shown
  • Johnson and Johnson
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Perrigo Company PLC
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Morepen Limited
  • Mankind Pharma Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll